NasdaqGM - Nasdaq Real Time Price USD

908 Devices Inc. (MASS)

Compare
2.9800
+0.0800
+(2.76%)
At close: January 17 at 4:00:01 PM EST
3.1500
+0.17
+(5.70%)
After hours: January 17 at 7:44:42 PM EST
Loading Chart for MASS
DELL
  • Previous Close 2.9000
  • Open 2.9200
  • Bid 2.9500 x 100
  • Ask 3.0100 x 100
  • Day's Range 2.7100 - 3.0500
  • 52 Week Range 1.8100 - 8.5000
  • Volume 1,347,390
  • Avg. Volume 589,093
  • Market Cap (intraday) 103.772M
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) --
  • EPS (TTM) -1.7900
  • Earnings Date Mar 3, 2025 - Mar 7, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.33

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

908devices.com

230

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MASS

View More

Performance Overview: MASS

Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

MASS
39.91%
S&P 500
1.52%

1-Year Return

MASS
61.60%
S&P 500
25.82%

3-Year Return

MASS
83.12%
S&P 500
28.61%

5-Year Return

MASS
93.45%
S&P 500
80.80%

Compare To: MASS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MASS

View More

Valuation Measures

Annual
As of 1/17/2025
  • Market Cap

    103.77M

  • Enterprise Value

    39.27M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.81

  • Price/Book (mrq)

    0.79

  • Enterprise Value/Revenue

    0.71

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -109.11%

  • Return on Assets (ttm)

    -15.56%

  • Return on Equity (ttm)

    -40.00%

  • Revenue (ttm)

    55.16M

  • Net Income Avi to Common (ttm)

    -60.19M

  • Diluted EPS (ttm)

    -1.7900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    71.69M

  • Total Debt/Equity (mrq)

    5.48%

  • Levered Free Cash Flow (ttm)

    -18.16M

Research Analysis: MASS

View More

Company Insights: MASS

Research Reports: MASS

View More

People Also Watch